Best-ever Q2: 90% PAT growth, 50% OPM hit, but macro headwinds loom
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A
Hit guidance on revenue (18% YoY), PAT (90% YoY), and margin (47.7% like-to-like vs 47%+ target). Reaffirmed FY28 50% margin target.
Optimistic
next 1–2 quarters
Optimistic
multi-year
LTH delivered a strong Q2 (90% PAT growth, 50% OPM) with margin expansion and occupancy momentum validated against guidance. However, corporate demand remains muted despite geopolitical uncertainty easing, and execution risks on key growth pillars (Aurika Nehru Place delays, Omaxe timelines, Fleur merger integration) warrant a cautious stance near-term. Asset-light strategy is bullish, but unproven at scale.
₹361.4 Cr
Revenue · +18% YoY₹79.8 Cr
Reported PAT · +90.2% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Best-ever second quarter with highest Q2 PAT
METPAT ₹79.8 Cr, up 90% YoY; prior Q2 baseline implied ~₹42 Cr
Like-to-like margins 47.7%, up 474 bps vs prior Q2
METReported OPM 50.3%; adjusted 47.7% excludes 3.2% SAR/GST impact
Revenue grew 18% YoY with balanced occupancy/ARR mix
METReported ₹363.8 Cr (vs delivered ₹361.4), ARR up 8%, occupancy 76.1% (+633 bps)
Occupancy surge driven by both leisure and corporate recovery
OVERSTATEDOccupancy 76.1% but corporate demand still muted due to geopolitical impact
Renovation capex normalizing to ~1% next year
METSpent Rs. 200 crore total CAPEX in FY27 (Bombay buyout, Shimla, etc.), baseline ₹2,000-2,100 Cr revenue run-rate
Earnings quality
What changed since the last call
Corporate demand narrative
DowngradeQ1 call was optimistic on corporate recovery post-West Asia conflict; Q2 delivery shows corporate still muted ('companies cutting down on discretionary travel'). Management now hedges: 'it is in the hands of God; we hope for 55/45 split between retail/corporate by H2.'
Aurika portfolio expansion roadmap
NeutralMaintained 2,000+ Keys net addition target for FY27. But Aurika Nehru Place (610 rooms) pushed from FY30 to CY31 due to DDA approvals. Shimla/Shillong/Varanasi on track. Net: timeline risk flagged but volume goal unchanged.
Capex guidance
MaintainedReaffirmed normalization to ~1% of revenue (from 2.25% in Q1). Total spent Rs. 200 Cr in FY27 YTD (Bombay buyout, land acquisitions, Shimla/Shillong). Next 3.5 years: ~₹3,000 Cr for new projects (Omaxe, Aurika pipeline).
Fleur EBITDAR margin assumption
NeutralFleur owned portfolio at 53% EBITDAR (up 112 bps YoY). Management expects blended EBITDA margin post-merger to reach 70%+ (from asset-light leverage). No change in target, but execution risk flagged ('depends on demerger timeline, construction challenges').
The Q&A
Analysts pressed hard on supply risk (Prachi Agarwal: IHCL/ITC expansion in luxury), Aurika unit economics (Achal Kumar: ₹8,900 ARR in Aurika Mumbai vs ₹25-30K at Marriott), capex/construction risk (Vaibbhav Muley: Bombay delays, environmental approvals). Management held firm: 'supply in Tier 2/3 is limited; our portfolio is in demand markets; renovations drive pricing power, not volume.' Tone was steady, not evasive.
FIT demand recovery signal — Karan Khanna, Ambit Capital
AnsweredWill stick to 55/45 guidance if geopolitical impact eases; corporate side still muted due to hiring freezes and IT sector slowdown; non-negotiated business picking up.
Hotel openings and deflags — Karan Khanna, Ambit Capital
AnsweredOpenings on track (gross 2,000 rooms); deflagging mostly Q1-Q2 due to compliance issues; expect no material deflagging in Q3-Q4. Gurgaon is force majeure (lease term), not systemic.
Aurika Nehru Place delays and ARR assumptions — Achal Kumar, HSBC
PartialDDA approvals delayed; expect construction to start in next 2-3 months. ARR of ₹12,000 is conservative; will achieve 12%-13% ROCE immediately at that level.
RevPAR split: ARR vs occupancy — Achal Kumar, HSBC
AnsweredBalanced. Q1 was occupancy-heavy (West Asia impact); Q2 more ARR-balanced (demand recovery, 8% ARR + occupancy gains). Long-term: occupancy and ARR will grow together.
F&B revenue growth divergence — Vaibbhav Muley, Haitong Securities
AnsweredFleur portfolio at 53% GOP margins; fees are ~40% function of EBITDA; GST and renovation caps fees this year; next year margins recover, fees accelerate.
ADR growth and GST impact — Vaibbhav Muley, Haitong Securities
AnsweredCurrently 50% of revenue above ₹7,500 (up from 48% prior year); gradual upside as renovations drive pricing. Focus is RevPAR, not ADR in isolation.
Gurgaon lease termination and exceptional items — Jinesh Joshi, PL Capital
AnsweredGurgaon: force majeure (fire removed banquet approval; lease terminated). Other deflagging (450 rooms) is ongoing due to compliance gaps, but management expects minimal future deflagging. Exceptional revenue (₹41 Cr) is non-cash accounting reversals.
Omaxe partnership terms and execution — Dikshi Jain, InCred Research
AnsweredAsset-light: Lemon Tree brands (Lemon Tree, Keys, Aurika). Two models: (a) Omaxe townships (Lucknow, Ghazabad, etc., 3-3.5 years); (b) PPP bus-station redevelopments (Tier 2/3, greenfield). ~400 rooms per property average. Greater Noida operational in next 12-18 months.
Fleur demerger timeline and 2,500-room operationalization — Dikshi Jain, InCred Research
PartialBy FY30-FY31 operational (brownfield/greenfield mix). Dependent on legal/technical diligence. 9 of 10 Omaxe properties are greenfield; expect 3-3.5 years to construct. One property (Greater Noida) next 12-18 months.
Supply-demand risk in luxury segment — Prachi Agarwal, Axis Capital
PartialSupply concentration in Tier 2/3 is limited; most growth is Tier 2/3, not luxury metros. Competitive but opportunity for us to increase network. Asset-light strategy allows us to grow without capital burden.
Loyalty program and repeat customer base — Rahul Majethia, Individual Investor
AnsweredCurrently 25% of business is loyalty; 45% is repeat guests (not loyalty members). Loyalty payout ~4% of revenue; breakage 30%-40%, actual consumption 60%-70%. Self-supporting internal system.
Franchise fee structures and escalation — Rahul Majethia, Individual Investor
AnsweredFees are revenue/EBITDA functions. No performance-linked escalators. Brand/distribution agreement; not operations control. 90%+ owners happy with performance; Lemon Tree is moral custodian.
Bandra land acquisition and ARR modeling — Achal Kumar, HSBC
AnsweredBandra-Kurla Complex is deep-demand market. Expected ARR ~₹12,000 at start; 12%-13% immediate ROCE. Comparable to other high-cost markets; will serve BKC clients.
Airline traffic divergence vs hotel demand — Sameet Sinha, Macquarie
AnsweredAirline data is proxy for FIT, not corporate. Corporate demand from internal hiring freezes (IT sector) and discretionary cuts. Retail and MICE recovering. Middle market is demand driver.
CAPEX guidance and renovation spend — Vaibbhav Muley, Haitong Securities
Answered60-65% renovation (OPEX), 35-40% capex (asset/land). Next 3.5 years: ~₹3,000 Cr total for new projects (Omaxe, Aurika, acquisitions). Renovation dropping to 1.2% of revenue next year from 2.25% in Q1.
Asset-light EBITDA margin trajectory — Zahra Patel, Solidarity Advisors
AnsweredYes. Hotels signed 3 years ago will ramp. Operating expenses at ₹100 Cr baseline; fee income targeting ₹500 Cr (₹400 Cr EBITDA, 80% flow-through). Expenses rise 4% annually; fees grow with volume.
Guidance
FY27: Double-digit growth achieved (18% YoY Q2 baseline)
HighQ2 at +18%; prior guidance 'Q2 onwards double-digit growth' confirmed. Full-year trajectory on track if H2 matches H1 momentum.
FY28: Capex normalized to ~1% of revenue from 2.25% in Q1
HighTotal FY27 capex ₹200 Cr (Rs. 2,100-2,200 Cr run-rate). Renovation dropping to 1.2% next year. Next 3.5 years ~₹3,000 Cr for new projects.
FY27 margins above 47% (maintained from prior call)
HighQ2 delivered 47.7% like-to-like (adjusted for SAR/GST 3.2% headwind). On track. Reported margin 44.6%, but on-track basis 47%+ achieved.
FY28 targeting 50% EBITDA margin (reaffirmed from prior call)
MediumFleur asset-light model targeting 70%+ EBITDA margin; Lemon Tree standalone margin expansion likely from renovation completion and operating leverage. No change vs prior, but achievable.
Total capex FY27-FY30: ~₹3,000 Cr for new projects (Omaxe, Aurika, acquisitions)
MediumDependent on acquisition closures (Omaxe, Warburg Pincus Fleur investment), construction timelines, and regulatory approvals. Aurika delays flagged; execution risk.
Risks the call surfaced
Corporate demand softness
MediumCorporate segment (target 55% of business) still muted despite geopolitical easing. IT hiring freezes and discretionary travel cuts offsetting leisure/MICE recovery. Analyst notes 'corporates slightly tepid to pick up.'
Execution risk on growth pipeline
HighAurika Nehru Place (610 rooms) delayed to CY31 from FY30 due to DDA tree-cutting approvals. Omaxe partnership (4,000 rooms) dependent on partner execution; 3-3.5 year timelines unproven. Fleur demerger CY27 contingent on NCLT approval.
Regulatory and compliance risk
Medium530 owned-hotel rooms deflagged in Q2 due to compliance gaps (Gurgaon lease termination, 450 rooms under review). SAR (Supplementary demands) and GST provisions creating 3.2% revenue headwind. Property tax demands from states pending.
Aurika brand positioning and unit economics
MediumAurika brand is new and unproven at scale. Aurika Mumbai selling at ₹8,900 ARR (analyst note: Marriott/luxury competitors at ₹25-30K). Aurika Nehru Place assumes ₹12,000 ARR start. Analyst skepticism: is Aurika a mid-market or luxury play?
Asset-light execution and partner dependency
MediumAsset-light model (Omaxe, franchisees) is bullish but shifts execution risk to partners. Fleur demerger pending; Omaxe partnership unproven; franchise fees dependent on partner RevPAR growth (not controlled).
Supply oversupply risk in key markets
LowLuxury segment seeing aggressive expansion by IHCL, ITC. Analyst (Prachi Agarwal) flagged 'supply outpacing demand, RevPAR growth model at risk.' Management counters: supply mostly Tier 2/3 (opportunity, not threat), and Lemon Tree is asset-light so can grow network without capital burden.
Management
Score 7/10. Transparent on challenges (deflagging, compliance, delays); candid on macro headwinds (corporate demand muted); specific on unit economics (Aurika ROCE, Fleur EBITDAR targets). Some evasion on H2 guidance ('difficult to explain'), but mostly forthcoming. Hit FY27 Q2 guidance (18% revenue, 90% PAT growth); maintained prior margin and capex targets; track record of delivery on annual guidance. Some delays (Aurika Nehru Place, Fleur demerger), but communicated transparently.
1 · Q3-Q4 FY27
Winter holiday season pickup; Diwali/festival demand recovery post-macro uncertainty
2 · FY28 (Apr 2027+)
Fleur Hotels Demerger listed; 2,500 rooms operationalized; merger synergy unlocked
3 · FY28-FY30
Omaxe partnership: 4,000 rooms across Tier 2/3 cities; fee-income leverage; no capex burden
Asset-light strategy is bullish, but unproven at scale.
Informational and educational content only. Not investment advice.